
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Illumina Inc (ILMN) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$185.64 after a previous close of US$186.43. During the day the price has varied from a low of USD181.17 to a high of USD187.2. The latest price was USD184.36 (25 minute delay). Illumina is listed on the NASDAQ. All prices are listed in US Dollars.
How to buy shares in Illumina
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Illumina. Find the share by name or ticker symbol: ILMN. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Illumina reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$186.43, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Illumina, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Illumina. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks

Our top pick for
Overall broker

Our top pick for
Low-cost broker

What's in this guide?
- Illumina key stats
- Compare share trading platforms
- Is Illumina stock a buy or sell?
- Illumina performance over time
- Is Illumina suitable for ethical investing?
- Are Illumina shares over-valued?
- Illumina's financials
- How volatile are Illumina shares?
- Does Illumina pay a dividend?
- Have Illumina shares ever split?
- Other common questions
Illumina stock price (NASDAQ:ILMN)
Use our graph to track the performance of ILMN stocks over time.Illumina shares at a glance
Open | US$185.64 |
---|---|
High | US$187.2 |
Low | US$181.17 |
Close | US$184.36 |
Previous close | US$186.43 |
Change | US$-2.07 |
Change % | -1.1103% |
Volume | 1,209,917 |
52-week range | US$180 - US$526 |
---|---|
50-day moving average | US$249.9176 |
200-day moving average | US$343.5346 |
Target price | US$341.13 |
PE ratio | 42.4479 |
Dividend yield | US$0 (0%) |
Earnings per share (TTM) | US$4.555 |
Compare trading apps to buy Illumina shares
Is it a good time to buy Illumina stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Illumina price performance over time
Historical closes compared with the last close of $184.36
1 week (2022-06-24) | -4.93% |
---|---|
3 months (2022-04-01) | -49.34% |
6 months (2021-12-31) | -51.54% |
1 year (2021-07-01) | -60.83% |
---|---|
2 years (2020-07-01) | -49.98% |
3 years (2019-07-01) | -50.26% |
5 years (2017-06-30) | 6.25% |
Stocks similar to Illumina
Is Illumina under- or over-valued?
Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Illumina's P/E ratio
Illumina's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Illumina shares trade at around 42x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Illumina's PEG ratio
Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4591. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Illumina's EBITDA
Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$937 million (£0.0 million).
The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.
Illumina financials
Revenue TTM | US$4.7 billion |
---|---|
Operating margin TTM | 13.81% |
Gross profit TTM | US$3.2 billion |
Return on assets TTM | 3.35% |
Return on equity TTM | 8.86% |
Profit margin | 15.06% |
Book value | 69.395 |
Market capitalisation | US$30.4 billion |
TTM: trailing 12 months
Illumina's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Illumina.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Illumina's total ESG risk score
Total ESG risk: 9.18
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Illumina's overall score of 9.18 (as at 01/01/2019) is excellent – landing it in it in the 2nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Illumina is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Illumina's environmental score
Environmental score: 2.22/100
Illumina's environmental score of 2.22 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Illumina's social score
Social score: 2.6/100
Illumina's social score of 2.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Illumina's governance score
Governance score: 5.36/100
Illumina's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Illumina is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Illumina's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Illumina scored a 1 out of 5 for controversy – the highest score possible, reflecting that Illumina has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Illumina Inc was last rated for ESG on: 2019-01-01.
Total ESG score | 9.18 |
---|---|
Total ESG percentile | 2.42 |
Environmental score | 2.22 |
Environmental score percentile | 2 |
Social score | 2.6 |
Social score percentile | 2 |
Governance score | 5.36 |
Governance score percentile | 2 |
Level of controversy | 1 |
Illumina share dividends
We're not expecting Illumina to pay a dividend over the next 12 months.
Have Illumina's shares ever split?
Illumina's shares were split on a 2:1 basis on 23 September 2008. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your Illumina shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Illumina shares which in turn could have impacted Illumina's share price.
Illumina share price volatility
Over the last 12 months, Illumina's shares have ranged in value from as little as US$180 up to US$526. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 1.0027. This would suggest that Illumina's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
Illumina overview
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Illumina in the news
Illumina's (ILMN) GRAIL to Offer Galleri Test in Indianapolis
Illumina Invests in £30M Venture Fund To Advance Breakthroughs in Human Health
The Soil Secrets That Could Help Feed the World
Frequently asked questions
More guides on Finder
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
-
How to buy Leo lithium (LLL) shares
Steps to owning and managing Leo lithium shares.
Ask an Expert